{"disease":{"id":"stage-iib-breast-cancer-t3n0","name":"stage iib breast cancer t3n0"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02751710","title":"Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":369,"lead_sponsor_name":"Ontario Clinical Oncology Group (OCOG)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}